AstraZeneca’s Imfinzi in combination with Imjudo plus platinum-based chemotherapy has been approved for treatment of patients with Stage IV non-small cell lung cancer (NSCLC). The approval has been made by the Food…
Category: Lung Cancer News
Role of Artificial Intelligence in Detecting Lung Cancer
The deadly disease of lung cancer is the leading cause of malignancy-related mortality worldwide owing to its diagnosis at a later stage. About 75% of those with lung cancer die within five…
Study Shows Circadian Rhythm Disruptions Linked To Enhanced Lung Cancer Growth
According to a new paper co-authored by University of Rochester Wilmot Cancer Institute investigator and led by the Scripps Research Institute in California, a vital molecular link is between growth of lung…
Electronic Nose to Detect Lung Cancer, Research Suggests
Research work and studies are continuously being done in the arena of lung cancer. Scientists and researchers continue to experiment new and effective ways to detect it at an early stage so…
Personalized Treatment for Small Cell Lung Cancer, MedUni Vienna Study Suggests
There are two main types of lung cancer: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). SCLC is a particularly aggressive form of tumor and is mainly treated with…
Scientists Discover New Gene Target for Aggressive Small Cell Lung Cancer
Lung cancer is the leading cause of cancer deaths in the United States. According to the American Cancer Society, an estimated 131,880 lung cancer deaths are predicted for this year alone. Though…
Air Pollution Causes Lung Cancer among Non-Smokers, New Research Suggests
Although scientists have long known that air pollution is linked with an increased risk of lung cancer, but new research suggests one mechanism that might explain how air pollution may trigger lung…
Experimental Drug Treatment Stops Lung Cancer in Mice
Small cell lung cancer is one of the deadly diseases and now scientists may have promising new avenue as they have been able to effectively stop the growth of small cell lung…
FDA Grants Approval to Trastuzumab Deruxtecan for HER2 Lung Cancer
Lung cancer patients now have another treatment option. For those tumors carrying HER2 mutations, can now be treated with trastuzumab deruxtecan. This drug is already approved for use in HER2-positive breast cancer…
Study Finds New Links between Genes and Lung Cancer
Lung Cancer is one of the most common cancers and according to the American Cancer Society; it is by far the leading cause of cancer deaths. August 1 is observed as World…
High Lung Cancer Risk among Smokers for Whom Screening is not Recommended
According to the research paper published in the Journal of the American Medical Association (JAMA) Oncology, some current and former older smokers who are not recommended for screening are at high risk…
Study finds Biomarker in Liquid Biopsy for Lung Cancer Appears Accurate in Predicting Immunotherapy Response
The researchers at Mount Sinai have found that a simple blood test called liquid biopsy could be a better indicator of whether cancer immunotherapy will be successful for lung cancer patients than…